Psoriatic arthritis (PsA) develops in four stages ... possibly leading to permanent disability. Polyarticular PsA affects five or more joints, often in a symmetrical pattern, similar to rheumatoid ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

Etanercept and adalimumab are highly effective for the management of severe or refractory polyarticular, extended-oligoarticular and juvenile psoriatic arthritis with polyarticular involvement.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

psoriatic arthritis disease activity outcome measures psoriasis ... become readily apparent when considering the subsets of PsA identified by Moll and Wright: oligoarticular, polyarticular, distal ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

According to GlobalData, Phase I drugs for Polyarticular Juvenile Idiopathic Arthritis ... It was also under development for the treatment of Sjogren syndrome, psoriatic arthritis, ankylosing ...

Objectives Patients with psoriatic arthritis (PsA) are at a significantly increased ... 24 Our descriptive analysis showed no relevant difference in the prevalence of polyarticular and enthesitis ...